Sotera Health (SHC) – Research Analysts’ Weekly Ratings Changes

A number of firms have modified their ratings and price targets on shares of Sotera Health (NASDAQ: SHC) recently:

• 1/1/2026 – Sotera Health was upgraded by analysts at Zacks Research from a “hold” rating to a “strong-buy” rating.
• 12/29/2025 – Sotera Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/22/2025 – Sotera Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/18/2025 – Sotera Health is now covered by analysts at William Blair. They set an “outperform” rating on the stock.
• 12/15/2025 – Sotera Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/8/2025 – Sotera Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/2/2025 – Sotera Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/26/2025 – Sotera Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/20/2025 – Sotera Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/14/2025 – Sotera Health was upgraded by analysts at Weiss Ratings from a “sell (d+)” rating to a “hold (c-)” rating.
• 11/13/2025 – Sotera Health is now covered by analysts at BMO Capital Markets. They set an “outperform” rating and a $19.00 price target on the stock.

Insider Activity at Sotera Health

In other news, Director Pincus & Co. Warburg sold 9,720,000 shares of the firm’s stock in a transaction dated Wednesday, December 3rd. The stock was sold at an average price of $16.33, for a total value of $158,727,600.00. Following the completion of the sale, the director directly owned 34,102,952 shares in the company, valued at $556,901,206.16. This trade represents a 22.18% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Gtcr Investment Xi Llc sold 12,000,000 shares of the firm’s stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $15.65, for a total value of $187,800,000.00. Following the completion of the sale, the director directly owned 29,215,301 shares of the company’s stock, valued at $457,219,460.65. This trade represents a 29.12% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 29,384,104 shares of company stock worth $471,824,511 over the last quarter. Company insiders own 47.55% of the company’s stock.

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.